Lishan Aklog - May 18, 2021 Form 4 Insider Report for CONTRAFECT Corp (CFRX)

Role
Director
Signature
/s/ Michael Messinger, attorney-in-fact for Lishan Aklog
Stock symbol
CFRX
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
4
Date filed
5/20/2021, 07:36 PM
Next filing
Oct 13, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CFRX Options (Right to Buy) Award $0 +25K $0.00 25K May 18, 2021 Common Stock 25K $3.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant award made under the ContraFect Corporation Omnibus Incentive Plan. Grant vests over one year, 25% at the end of each quarter following the vesting commencement date.